Pharmacy Market BUZZ

Market News, Products, Services, and Trends

Meet the ScanRDI® Rapid Sterility Test - Speed Up Your Sterility Compliance


The current 14-day incubation period required for USP<71> sterility compliance means many sterile compounds will have a severely limited shelf life. Compounding pharmacies must meet the challenge of providing safe medications that are produced using validated methodology or risk failing an FDA inspection.


Eagle Analytical offers an FDA-accepted alternative to official compendial sterility test methods. The ScanRDI® Rapid Sterility Test detects viable microbial cells down to one microorganism without the need for growth or cell multiplication. This USP<1223>-approved style of testing provides USP<71>-compliant results in just one day.


ScanRDI_FDA-Accepted.png




Today's Posts
Subscribe



What are SPOTLIGHTS?

SPOTLIGHTS are brief (30-second) introductions to companies, products, product features,
and services that could potentially benefit the pharmacy operations of RXinsider's readership.


Spotlights2.png

Suggest a SPOTLIGHT

To suggest a subject to be profiled in a SPOTLIGHT, please contact 
your RXinsider Account Manager or RXinsider's Pharmacy Market Analyst Jeff Mazzamuro, PharmD.




This post is related to:

Compounding: Supplies, Equipment, Training Quality Control/Analytical Testing